REPOSE
DEAD

Serial Number

79359477

Owner

Saluda Medical Pty Ltd

Filing Date

May 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

REPOSE Trademark

Serial Number: 79359477

REPOSE is a trademark filed by Saluda Medical Pty Ltd on May 24, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Saluda Medical Pty Ltd (33 trademarks)

Level 2,
Macquarie Park NSW 2113 , AU

Entity Type: 99

Trademark Details

Filing Date

May 24, 2022

Registration Date

Not Registered

Goods & Services

Computer software for programming and monitoring neuromodulation applications; computer systems for neuromodulation therapy to provide therapeutic relief of various bladder and bowel conditions; communication software; data processing software; application software; application software for cloud computing services; interface software; application software for mobile devices; mobile applications; apparatus for data storage; data management software; artificial intelligence software for data analysis of neuromodulation; artificial intelligence software for healthcare; machine learning software; computer hardware; data processing systems; monitoring apparatus and instruments; software for monitoring and programming neuromodulation parameters; measuring, diagnostic software; activity trackers; parts and fittings for all of the aforesaid goods

Health consultancy; healthcare services; healthcare information services; healthcare advisory services related to neuromodulation therapy; health clinical services; health screening services; medical health assessment services; therapy services; monitoring of patients; medical care and analysis services relating to treating bladder disorders; preparation of reports concerning neuromodulation, providing news and information in the field of neuromodulation (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); providing medical information; information and advisory related to all of the aforesaid services about neuromodulation therapy, all the foregoing excluding massage services

Medical apparatus excluding mattresses; apparatus for neurostimulation; apparatus for analysing physiological parameters for neuromodulation purposes; medical devices excluding mattresses; electro-medical instruments; medical testing instruments; medical instruments for recording physiological data; electronic monitoring instruments for medical use; parts and fittings for all of the aforesaid goods; neuromodulation systems for providing therapeutic relief of various bladder and bowel conditions

Scientific and technological services; scientific research services; scientific research relating to neuromodulation; research and development services relating to neuromodulation; research and development services relating to neurostimulation; providing medical and scientific research information in the field of neuromodulation; provision of scientific information, development and testing of computer methods, algorithms and software; software as a service [saas]; platform as a service [paas]; data as a service (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); providing information and data relating to scientific and technological research and development; design and development of software and hardware; updating and maintenance of software; information technology services for the pharmaceutical and healthcare industries (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); writing of computer programs for medical applications; compilation of computer programmes for research data in the field of medical science and medical consultancy; information and advisory related to all of the aforesaid services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 13, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2024 FICR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 12, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 12, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 12, 2023 ABN2
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 24, 2023 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2023 NREP
REFUSAL PROCESSED BY IB
Jun 19, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 31, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2023 REPR